Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaozhenjiedu formula (also known as Xiaozhenjiedu decoction or recipe) is a traditional Chinese medicine (TCM) herbal formula developed by the Oncology Department at the Guangdong Provincial Hospital of Chinese Medicine. It is formulated as a topical wash or wet compress to treat epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)-related skin toxicities, such as papulopustular rash, in patients with non-small cell lung cancer (NSCLC). The formula is designed to clear heat, resolve toxins, and alleviate skin irritation and rash associated with targeted cancer therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaozhenjiedu formula.